NO20005681L - Nye formuleringer som inneholder paroxetin - Google Patents

Nye formuleringer som inneholder paroxetin

Info

Publication number
NO20005681L
NO20005681L NO20005681A NO20005681A NO20005681L NO 20005681 L NO20005681 L NO 20005681L NO 20005681 A NO20005681 A NO 20005681A NO 20005681 A NO20005681 A NO 20005681A NO 20005681 L NO20005681 L NO 20005681L
Authority
NO
Norway
Prior art keywords
formulations containing
new formulations
containing paroxetine
paroxetine
hemihydrate
Prior art date
Application number
NO20005681A
Other languages
English (en)
Other versions
NO20005681D0 (no
Inventor
David Philip Elder
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20005681D0 publication Critical patent/NO20005681D0/no
Publication of NO20005681L publication Critical patent/NO20005681L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/485—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Paroxetinhydroklorid, i en annen form enn hemihydratet, som er anvendt i kapsler under slike betingelser at det ikke er noen påviselig omdannelse til hemihydrat under produksjonsprosessen.
NO20005681A 1998-05-13 2000-11-10 Nye formuleringer som inneholder paroxetin NO20005681L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9810180.1A GB9810180D0 (en) 1998-05-13 1998-05-13 Novel formulation
PCT/GB1999/001522 WO1999058116A2 (en) 1998-05-13 1999-05-13 Novel formulation containing paroxetine

Publications (2)

Publication Number Publication Date
NO20005681D0 NO20005681D0 (no) 2000-11-10
NO20005681L true NO20005681L (no) 2000-12-01

Family

ID=10831926

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005681A NO20005681L (no) 1998-05-13 2000-11-10 Nye formuleringer som inneholder paroxetin

Country Status (20)

Country Link
EP (1) EP1077685A2 (no)
JP (1) JP2002514593A (no)
KR (1) KR20010043545A (no)
CN (1) CN1309557A (no)
AP (1) AP2000001985A0 (no)
AU (1) AU3941099A (no)
BG (1) BG105011A (no)
BR (1) BR9910402A (no)
CA (1) CA2331849A1 (no)
EA (1) EA200001173A1 (no)
GB (1) GB9810180D0 (no)
HU (1) HUP0101931A3 (no)
ID (1) ID27018A (no)
IL (1) IL139596A0 (no)
NO (1) NO20005681L (no)
PL (1) PL344872A1 (no)
SK (1) SK16972000A3 (no)
TR (1) TR200003351T2 (no)
WO (1) WO1999058116A2 (no)
ZA (1) ZA200006465B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1161241B1 (de) * 1999-03-12 2005-12-07 Aesica Pharmaceuticals Ltd. Stabile pharmazeutische anwendungsform für paroxetin-anhydrat
HU226912B1 (en) * 2000-04-07 2010-03-01 Richter Gedeon Nyrt New paroxetin salt and medicament containing it
JP6062422B2 (ja) * 2012-03-29 2017-01-18 杏林製薬株式会社 カプセル製剤
DE102013207447A1 (de) 2013-04-24 2014-10-30 Evonik Degussa Gmbh Verfahren und Vorrichtung zur Herstellung von Octachlortrisilan
CN103520131B (zh) * 2013-10-12 2019-05-14 浙江华海药业股份有限公司 盐酸帕罗西汀半水合物胶囊的制备方法
CN103961333B (zh) * 2014-05-07 2020-02-21 浙江华海药业股份有限公司 甲磺酸帕罗西汀胶囊及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996031197A1 (en) * 1995-04-03 1996-10-10 Abbott Laboratories Homogeneous mixtures of low temperature-melting drugs and additives for controlled release
GB9724544D0 (en) * 1997-11-21 1998-01-21 Smithkline Beecham Plc Novel Formulation

Also Published As

Publication number Publication date
PL344872A1 (en) 2001-11-19
NO20005681D0 (no) 2000-11-10
WO1999058116A3 (en) 2000-02-17
AU3941099A (en) 1999-11-29
HUP0101931A2 (hu) 2002-04-29
JP2002514593A (ja) 2002-05-21
KR20010043545A (ko) 2001-05-25
CA2331849A1 (en) 1999-11-18
ZA200006465B (en) 2001-11-09
BR9910402A (pt) 2001-01-09
IL139596A0 (en) 2002-02-10
EP1077685A2 (en) 2001-02-28
HUP0101931A3 (en) 2002-10-28
GB9810180D0 (en) 1998-07-08
BG105011A (en) 2001-07-31
WO1999058116A2 (en) 1999-11-18
CN1309557A (zh) 2001-08-22
TR200003351T2 (tr) 2001-03-21
EA200001173A1 (ru) 2001-04-23
AP2000001985A0 (en) 2000-12-31
ID27018A (id) 2001-02-22
SK16972000A3 (sk) 2001-06-11

Similar Documents

Publication Publication Date Title
EA199800140A1 (ru) Композиции с контролируемым высвобождением пароксетина
LT2003017A (en) Polymorphs of an epothilone analog
HUP9903741A2 (hu) Asztmaellenes, allergiaellenes, immunvisszaszorító és/vagy immunmoduláló hatású N-helyettesített indol-3-glioxilamidok
MXPA03004386A (es) Compuestos bis-arilo sustituidos en la posicion orto y meta, procesos para su preparacion, su uso como medicamento, y las preparaciones farmaceuticas que los contienen.
CO4290417A1 (es) Nuevas benzoilguanidinas como medicamentos y su preparacion .
RS50258B (sr) Postupak za pripremanje citaloprama
MX9700273A (es) Benzamidinas sustituidas, su preparacion y empleo como sustancias medicamentosas.
EA200400455A1 (ru) Способ приготовления быстрорастворимой дозировочной формы
EA200500213A1 (ru) Диспергируемые таблетки для орального назначения
NO20005681L (no) Nye formuleringer som inneholder paroxetin
ATE291908T1 (de) Ibuprofen-wirkstoffzubereitung
YU45395A (sh) Novo hemijsko jedinjenje, njegovo pripremanje i njegova primena kao leka
GEP20063972B (en) Streptogramin derivatives, preparation and compositions containing them
TW200501943A (en) Escitalopram hydrobromide and a method for the preparation thereof
DK0755919T3 (da) Substituerede kanelsyreguanidider, fremgangsmåde til deres fremstilling, deres anvendelse som hjerte-kredsløbs-medikament e
IS3659A7 (is) Ný aðferð við að framleiða útskipt 4-fenýl-4-píperídínkarboxamíð sem hefur bæði staðbundin deyfandi og kvalastillandi áhrif
EE9400296A (et) Piperidinüültioindooli derivaadid, ravimvormid, aktiivne valuvaigisti, nende valmistamise meetodid
NO20005683L (no) Ny formulering inneholdende paroxetin
NO20004919L (no) Fremgangsmåte for fremstilling av 5-hydroksybenzo[b]tiofen-3- karboksylsyrederivater
NO980906L (no) Nye, antikonvulsivt virkende 1-ar(alk)yl-imidazolin-2-oner, som i 4-stilling inneholder en disubstituert aminrest og en fremgangsmåte for deres fremstilling
MX2020010400A (es) Formulacion de goma oral y proceso de preparacion de la misma.
AU1022201A (en) Novel LTB4 antagonist, method for the production thereof and its use as a medicament
MXPA04001856A (es) Indan-1-oles c2-sustituidos y sus derivados, metodo para su produccion y su uso como medicamentos.
MXPA04001852A (es) Uso de sistemas indan-1-ol c2-sustituidas para la produccion de medicamentos para la profilaxis o tratamiento de obesidad.
DK1370529T3 (da) Substituerede dimethyl-[-1(1-phenyl-cyclohexyl)-piperidin-3-ylmethyl]-aminer og anvendelse som analgetika

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application